| Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins KDP Dorayappan, R Wanner, JJ Wallbillich, U Saini, R Zingarelli, ... Oncogene 37 (28), 3806-3821, 2018 | 283 | 2018 |
| Vulvar intraepithelial neoplasia (VIN 2/3): comparing clinical outcomes and evaluating risk factors for recurrence JJ Wallbillich, HE Rhodes, AM Milbourne, MF Munsell, M Frumovitz, ... Gynecologic oncology 127 (2), 312-315, 2012 | 129 | 2012 |
| Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target U Saini, S Naidu, AC ElNaggar, HK Bid, JJ Wallbillich, K Bixel, C Bolyard, ... Oncogene 36 (2), 168-181, 2017 | 123 | 2017 |
| The biological significance and clinical applications of exosomes in ovarian cancer KDP Dorayappan, JJ Wallbillich, DE Cohn, K Selvendiran Gynecologic oncology 142 (1), 199-205, 2016 | 94 | 2016 |
| High glucose-mediated STAT3 activation in endometrial cancer is inhibited by metformin: therapeutic implications for endometrial cancer JJ Wallbillich, S Josyula, U Saini, RA Zingarelli, KDP Dorayappan, ... PLoS One 12 (1), e0170318, 2017 | 54 | 2017 |
| Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix AB Costales, AM Milbourne, HE Rhodes, MF Munsell, JJ Wallbillich, ... Gynecologic oncology 129 (3), 513-516, 2013 | 50 | 2013 |
| STAT3/PIAS3 levels serve as “early signature” genes in the development of high-grade serous carcinoma from the fallopian tube U Saini, AA Suarez, S Naidu, JJ Wallbillich, K Bixel, RA Wanner, J Bice, ... Cancer research 78 (7), 1739-1750, 2018 | 22 | 2018 |
| Vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin, and etoposide (VPCBAE) in the management of three patients with small-cell carcinoma of the ovary JJ Wallbillich, AM Nick, PT Ramirez, JL Watkins, ED Euscher, ... Gynecologic Oncology Case Reports 2 (2), 58-60, 2012 | 22 | 2012 |
| A personalized paradigm in the treatment of platinum-resistant ovarian cancer–a cost utility analysis of genomic-based versus cytotoxic therapy JJ Wallbillich, B Forde, LJ Havrilesky, DE Cohn Gynecologic oncology 142 (1), 144-149, 2016 | 19 | 2016 |
| Comparing mutation frequencies for homologous recombination genes in uterine serous and high-grade serous ovarian carcinomas: A case for homologous recombination deficiency … JJ Wallbillich, RT Morris, R Ali-Fehmi Gynecologic Oncology, 2020 | 17 | 2020 |
| Comparing mutation frequencies for homologous recombination genes in uterine serous and high-grade serous ovarian carcinomas: A case for homologous recombination deficiency … JJ Wallbillich, RT Morris, R Ali-Fehmi SGO 2020 Annual Meeting on Women's Cancer, 2020 | 17 | 2020 |
| Better survival is observed in cervical cancer patients positive for specific anti-glycan antibodies and receiving brachytherapy S Purohit, DG Ferris, M Alvarez, PMH Tran, LKH Tran, DP Mysona, ... Gynecologic oncology 157 (1), 181-187, 2020 | 11 | 2020 |
| The genomic landscape of vulvar squamous cell carcinoma L Corey, JJ Wallbillich, S Wu, A Farrell, K Hodges, J Xiu, C Nabhan, ... International Journal of Gynecological Pathology 42 (5), 515-522, 2023 | 10 | 2023 |
| Identification of a transcriptomic signature with excellent survival prediction for squamous cell carcinoma of the cervix JJ Wallbillich, PMH Tran, S Bai, LKH Tran, AK Sharma, SA Ghamande, ... American Journal of Cancer Research 10 (5), 1534, 2020 | 10 | 2020 |
| Changes in microRNA expression associated with metastasis and survival in patients with uveal melanoma A Vashishtha, TJ Lee, A Sharma, JJ Wallbillich Oncotarget 11 (16), 1435, 2020 | 8 | 2020 |
| Molecular profiling of gestational trophoblastic neoplasia: identifying therapeutic targets L McNally, S Wu, K Hodges, M Oberley, JJ Wallbillich, NL Jones, ... Gynecologic oncology 184, 111-116, 2024 | 4 | 2024 |
| Quality of life in endometrial cancer survivors by grade of disease K Banning, J Fucinari, A Fielder, JJ Ruterbusch, JL Beebe‐Dimmer, ... Cancer Medicine 12 (12), 13675-13686, 2023 | 4 | 2023 |
| A 73-gene proliferative transcriptomic signature predicts uterine serous carcinoma patient survival and response to primary therapy LKH Tran, PMH Tran, DP Mysona, SB Purohit, E Myers, WS Lee, B Dun, ... Gynecologic Oncology 157 (2), 340-347, 2020 | 3 | 2020 |
| Participation in clinical trials may overcome health disparities in the treatment of advanced or recurrent epithelial ovarian cancer KB Patel, A Pyrzak, H Williams, H Coste, LF Zhang, R Sadek, ... Gynecologic Oncology 149, 4-5, 2018 | 3 | 2018 |
| Hypoxia-facilitated exosomal release from ovarian cancer cells is regulated by STAT3 and is associated with increased metastatic tumor burden KDP Dorayappan, JJ Wallbillich, U Saini, K Bixel, MK Riley, RA Zingarelli, ... Gynecologic oncology 141, 66, 2016 | 3 | 2016 |
Adrian A. SuarezThe Ohio State University Department of PathologyVerificeret mail på osumc.edu
